Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …

ABSTRACT Introduction: The atypical antipsychotic (APs) drugs have become the most
widely used agents to treat a variety of psychoses because of their superiority with regard to …

Introduction: Pharmacokinetic and pharmacodynamic drug interactions (DIs) can occur
between antiepileptics (AEDs) and second-generation antipsychotics (SGAPs). Some AED …

The aim of this paper was to review the up-to-date evidence base on pharmacology and
clinical properties of lurasidone. Lurasidone is an atypical antipsychotic, approved by the US …

Objectives: To assess the efficacy and tolerability of lurasidone versus other atypical
antipsychotic monotherapy agents in patients with bipolar depression, using a Bayesian …

This drug review presents a comprehensive review of Cariprazine, a medication that
received FDA approval in 2015 for treating schizophrenia and bipolar disorder. The paper …

The treatment of schizophrenia includes the control of symptoms, the prevention of relapses,
and amelioration of adaptive skills for patient re-integration into society. Antipsychotic drugs …

Lurasidone is a new atypical antipsychotic in the benzoisothiazoles class of chemicals. Like
most second-generation antipsychotics it is a full antagonist at dopamine D2 and serotonin 5 …

Introduction: Depressive symptoms and episodes dominate the course of bipolar disorder.
The morbidity of bipolar disorder is disproportionately mediated by depressive symptoms; …

Antipsychotic drugs (APDs) are some of the most frequently prescribed medications, not only
for psychotic disorders and symptoms but also for a wide range of both onlabel and off-label …